Not enough history yet — the model records AIZ's score after each daily run, and the chart appears once a few days have accumulated.
AIZ at a glance
Every figure here comes from the same audited fundamentals behind the score. Charts drawn from data the score does not use say so on the card.
Analyst estimate revisions
| 30-day change | +3.6% |
|---|---|
| 90-day change | +3.8% |
| Forward EPS estimate | $23.32 |
Over the last 90 days, what analysts expect AIZ to earn is drifting higher (+3.8%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Latest AIZ developments
Recent headlines from across the financial press · updated daily. Links open the source.
- Do Wall Street Analysts Like Assurant Stock?Barchart.com ·
- Assurant stock holds steady as mobile trade-ins return $1.43 billion in Q2 2026Ad-hoc-news.de ·
- Assurant Inc. stock outperforms competitors on strong trading dayMarketWatch ·
- Assurant stock holds firm after a $320 target callAd-hoc-news.de ·
- Assurant stock holds steady as buy-rated outlook and $316.57 target frame valuationAd-hoc-news.de ·
- Assurant Inc. stock underperforms Monday when compared to competitors despite daily gainsMarketWatch ·
Assurant, Inc. (AIZ): score, valuation & FAQ
Assurant, Inc. (AIZ) is a Insurance - Property & Casualty company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.
Its strongest graded signals are ROE (B+).
Is AIZ a good stock to buy?
Bull Rankings grades AIZ on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. That is driven by ROE (B+). A score is a quantitative screen of Assurant, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
How does Bull Rankings grade AIZ?
As a bank, insurer or REIT, AIZ isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage, where it rates strongest on ROE (B+).
Is AIZ overvalued or undervalued?
We don't compute a reliable discounted-cash-flow value for AIZ — typically because it is not yet consistently profitable or free-cash-flow positive — so its valuation rests on growth and price-to-sales rather than on earnings-based intrinsic value. Judge it on the trajectory of the business, not a single multiple.
What are the main risks of investing in AIZ?
The bear case centers on the modest 7.9% revenue growth, which may stall if device replacement cycles lengthen or if insurers face pricing pressure, compressing the already thin 7.9% profit margin. A P/E of 13.7, while reasonable, suggests the market has priced in near‑term growth; a slowdown would force the stock toward the lower end of its 52‑week range ($205). A breach of the 52‑week low would confirm the growth story is unraveling.
New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.